Table 3.
Drug and treatment-related factors of DM patients visiting DCSH, 2023 (n = 392)
| Variables | Categories | Frequency | % |
|---|---|---|---|
| Types of DM | Type 1 | 162 | 41.3 |
| Type 2 | 230 | 58.7 | |
| Presence of comorbidities | Yes | 108 | 27.6 |
| No | 284 | 72.4 | |
| Family history of DM | Yes | 28 | 7.1 |
| No | 364 | 92.9 | |
| Number of drugs prescribed | One | 244 | 62.2 |
| Two | 65 | 16.6 | |
| 3 and above | 83 | 21.2 | |
| type of treatment | Biguanides | 202 | 51.5 |
| Sulfonylureas | 50 | 12.8 | |
| Insulin | 128 | 32.7 | |
| Mixed | 12 | 3.1 | |
| Nature of prescription | Essential | 313 | 79.8 |
| Generic | 69 | 17.6 | |
| Brand | 10 | 2.6 | |
| Duration of disease | < 10 years | 370 | 94.4 |
| >= 10 years | 22 | 5.6 | |
| Number of follow-ups per month | 1 time | 365 | 93.1 |
| > 1 times | 27 | 6.9 |